Recombinant Human Interleukin-7 (CYT107) to Promote T-Cell Recovery After Cord Blood Transplantation

NCT03600896 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Supply issues from Sponsor

Conditions

Umbilical Cord Blood Transplant

Interventions

DRUG: CYT107

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]